Skip to main content
ALC logo
ALC
(NYSE)
Alcon Inc.
$67.28-- (--)
Loading... - Market loading

Alcon (ALC) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Alcon Inc.
ALCNew York Stock Exchange

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Company Information

CEODavid Endicott
Founded1945
Employees25,942
CountrySwitzerland
Fiscal YearJanuary - December

Stock Details

ExchangeNew York Stock Exchange (NYSE)
CurrencyUSD - USD
TypeStock

Contact Information

Phone41 589 112 110
Address
Chemin de Blandonnet 8 Geneva, 1214 Switzerland

Corporate Identifiers

CUSIPH01301128
ISINCH0432492467
SIC3851

Leadership Team & Key Executives

David Endicott
Chief Executive Officer
Timothy Stonesifer
Chief Financial Officer
Ian Bell
Chief Operating Officer